Ulla Møller W.
- Country
- Denmark
- Department
- Respiratory Research Unit
Research Overview
- A seamless, phase 1b/2 multiple ascending dose/proof of concept study of XTMAB-16 in patients with pulmonary sarcoidosis with or without extrapulmonary manifestations
- Phase 1b/2 Multiple Ascending Dose Study of Intravenous XTMAB-16 in Patients with Pulmonary Sarcoidosis (with or without Extrapulmonary Manifestations)
Data & Insights
Has run more than one trial at 13 of 20 partner sites.
Specializations
Respiratory Diseases
This investigator specializes in studying various forms of severe respiratory conditions, with particular emphasis on chronic inflammatory airway diseases.
- Severe Asthma Management
- Chronic Obstructive Pulmonary Disease (COPD)
- Bronchiectasis
Their work includes evaluation of novel therapeutic approaches for patients with uncontrolled respiratory symptoms.
Specialized Conditions
The investigator focuses on treating complex respiratory infections and inflammatory conditions requiring specialized interventions.
- Pulmonary Sarcoidosis
- Nontuberculous Mycobacterial Infections
- Severe Viral Lung Infections
Their research encompasses both pulmonary manifestations and systemic complications of these conditions.
Therapeutic Approaches
The investigator explores innovative treatment modalities and therapeutic strategies for respiratory conditions.
- Biological Therapies
- Inhalation Treatments
- Combination Therapy Optimization
Their work includes assessment of treatment efficacy in reducing exacerbations and improving patient outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.